$44.87
arrow_drop_up1.19%Key Stats | |
---|---|
Open | $44.93 |
Prev. Close | $44.43 |
EPS | -6.43 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 43.98 | 46.11 |
52 Week Range | 19.79 | 53.29 |
Ratios | |
---|---|
EPS | -6.43 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
Prestige Consumer Healthcare (PBH) Down 0.4% Since Last Earnings Report: Can It Rebound?